)
Pacific Biosciences (PACB) investor relations material
Pacific Biosciences Canaccord Bus Tour presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic priorities and growth initiatives
Focus on executing SPRQ-Nx chemistry rollout and launching a high-throughput platform.
Restructuring to align marketing and commercial teams with clinical and commercial accounts.
Expansion into clinical and commercial markets, aiming for cash flow breakeven by 2028.
Emphasis on enabling discovery and AI biological models.
Product and technology advancements
SPRQ-Nx chemistry launched in May 2026, with ~50% of installed base opted in by Q3.
U.S. list price per genome reduced to $345, enhancing competitiveness for large-scale projects.
Multi-use SMRT cells drive lower costs and higher throughput.
High-throughput platform launch planned to further expand capabilities.
AI and data partnerships
Largest project to date: Trillion Gene Atlas with Basecamp Research, targeting over 100 million samples.
Long-read sequencing data positioned as essential for training advanced AI models.
Collaborations with NVIDIA and Anthropic to advance generative biology.
Efforts underway to make data more accessible and licensable.
- SPRQ-Nx rollout and clinical focus aim to boost margins and drive sustainable growth.PACB
Morgan Stanley 24th Annual Global Healthcare Conference - Strong clinical growth, new product launches, and cost cuts set stage for 2027–2028 profitability.PACB
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue was $39.0M, with lower margins and guidance, and major restructuring actions.PACB
Q2 2026 - SPARQ-Nx and workflow advances fuel clinical growth, margin gains, and global expansion.PACB
TD Cowen 46th Annual Health Care Conference - Record consumable growth, clinical expansion, and cost discipline drive path to profitability.PACB
Goldman Sachs 46th Annual Global Healthcare Conference - Long read sequencing adoption is accelerating due to cost parity, clinical demand, and new data advantages.PACB
Stephens Annual Investment Conference - Record consumables and improved margins offset lower instrument sales, with new technology launched.PACB
Q3 2025 - Q3 revenue up sequentially, new products and debt restructuring set stage for 2025 growth.PACB
Q3 2024 - Record consumables growth and cost cuts offset weak instrument sales and major restructuring losses.PACB
Q1 2025
Next Pacific Biosciences earnings date
Next Pacific Biosciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)